Sol-Gel Technologies’ work to expand the treatment options for patients with the skin condition rosacea has paid off, with the FDA approving a product based on its microencapsulation technology.

H.C. Wainwright analyst Raghuram Selvaraju raised the firm’s price target on Sol-Gel Technologies (SLGL) to $50 from $6 and keeps a Buy rating on ...

Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for Gorlin syndrome and extending cash runway to 2027. Sol-Gel Technologies, Ltd. has announced a product purchase ...

Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "The Global Sol-Gel Coatings Market 2025-2035" report has been added to ResearchAndMarkets.com's offering. The Global Sol-Gel Coatings Market 2025-2035 ...

Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), is pleased to announce that it ...

PreveCeutical Medical (OTCQB:PRVCF) said it granted Endosane Pharmaceuticals an option to license sol-gel technology for the delivery of cannabinoid products on an exclusive basis. The purpose of the ...

Sol-gel manufacturing can be used to create various high-performance solids including glasses and ceramics. In the field of glass production, sol-gel techniques are a reliable low-temperature ...

Fintel reports that on October 27, 2025, HC Wainwright & Co. maintained coverage of Sol-Gel Technologies (NasdaqCM:SLGL) with a Buy recommendation. Analyst Price Forecast Suggests 53.85% Upside As of ...

The University of Queensland has struck a deal with Canadian health and wellness company PreveCeutical Medical which could revolutionize the way patients take medical cannabis. Invented at the UQ ...